Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-02-02
2000-09-19
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 81, 514 89, 514 94, 514256, 514258, 514397, 514424, 514425, 4241571, 4241581, 4241691, 4241701, 4242361, 4242411, 4242571, 4242601, 4242651, 544235, 544243, 544244, 544262, 544335, 546 22, 5462784, 5462787, 5483147, 548413, A61K 3140, C07D20708
Patent
active
061212962
ABSTRACT:
This invention is directed to transition-state analog compounds and to the use of said compounds as inhibitors of nucleoside hydrolase and transferase enzyme activity of parasites. This invention is further directed to the use of said compounds to treat infections and diseases caused by certain bacterial and plant toxins.
REFERENCES:
patent: 2878264 (1959-03-01), Lunsford
patent: 5041555 (1991-08-01), Fleet et al.
patent: 5089520 (1992-02-01), Fleet et al.
patent: 5098927 (1992-03-01), Takatsuki et al.
"Enzyme-Catalyzed Aldol Condensation for Asymmetric Synthesis of Azasugars: Synthesis, Evaluation, and Modeling of Glycosidase Inhibitors" by Kajimoto, in J. Am. Chem. Soc., vol. 113, pp. 6187-6196 (1991).
"Amino-SubstituTed-.beta.-Benzyl-C-Glycosides; Novel .beta.-Glycosidase Inhibitors" by Schmidt et al., in Angew. Chem. Int. Ed. Engl., vol. 30, pp. 1328-1329 (1991).
"Enzyme-Catalyzed Synthesis of 1-Deoxymannojirimycin, 1-Deoxynojirimycin, and 1,4-Dideoxy-1,4-Imino-D-Arabinitol" by Ziegler et al., in Angew. Chem. Int. Ed. engl., Vol. 27, No.5, pp. 716-717 (1988).
"Potent Competitive Inhibition of .alpha.-Galactosidase and .alpha.Glucosidase Activity by 1,4-Dideoxy-1,4-IminopentiTols: Syntheses of 1,4-Dideoxy-1,4-Imino-D-Lyxitol and of Both Enantiomers of 1,4-Dideoxy-1,4-Iminoarabinitol" by Fleet et al., in Tetrahedron Letters, vol. 26, No. 26, pp. 3127-3130 (1995).
Parkin, et al., Nucleoside Hydrolase from Crithidia fasciculata, J. Biol. Chem., 1991, 266(31), 20658-20665.
Horenstein, et al., Transition State Analysis of Nucleoside Hydrolase from Crithidia fasciculata, Biochemistry, 1991, 30(44), 10788-10795.
Kline and Schramm, Purine Nucleoside Phosphorylase. Ionine Hydrolysis, Tight Binding of the Hypoxanthine Intermediate, and Third-the-Sites Reactivity, Biochemistry, 1992, 31, 5964-5973.
Horenstein and Schramm, Electronic Nature of the Transition State for Nucleoside Hydrolase. A Blueprint for Inhibitor Design, Biochemistry, 1993, 32, 7089-7097.
Horenstein and Schramm, Correlation of the Molecular Electrostatic Potential Surface of an Enzymatic Transition State with Novel Transition-State Inhibitors, Biochemistry, 1993, 32, 9917-9925.
Boutellier, et al., Amidrazone Analogues of D-Ribofuranose as Transition-State Inhibitors of Nucleoside Hydrolase, Biolchemistry, 1994, 33, 3994-4000.
Schramm, et al., Transition State Analysis and Inhibitor Design for Enzymatic Reactions, Journal of Biological Chemistry, 1994, 269(28), 18259-18262.
Estupinan and Schramm, Guanosine-Inosine-Preferring Nucleoside N-Glycohydrolase from Crithidia fasciculata, Journal of Biological Chemistry, 1994, 269(37) 23068-23073.
Kline and Schramm, Pre-Steady-State Transition-State Analysis of the Hydrolytic Reaction Catalyzed by Purine Nucleoside Phosphorylase, Biolchemistry, 1995, 34, 1153-1162.
Parkin and Schramm, Binding Modes for Substrate and a Proposed Transition-State Analogue of Protozoan Nucleoside Hydrolase, Biochemistry, 1995, 34, 13961-13966.
Degano, et al., Three-Dimensional Structure of the Inosine-Uridine Nucleoside N-Ribohydrolase from Crithidia fasciculata, Biochemistry, 1996, 35, 5971-5981.
Chen, et al., Inhibition of Ricin by an RNA Stem-Loop Containing a Ribo-Oxocarbenium Mimic, Journal of the American Chemical Society, 1996, 118, 3067-3068.
Parkin et al., Isozyme-Specific Transition State inhibitors for the Trypanosomal Nucleoside Hydrolases, Biochemistry, 1997, 36, 3528-3534.
Furneaux, et al., Synthesis of Transition State Inhibitors for N-Riboside Hydrolases and Transferases, 1997, 53(8); 2915-2930.
Horenstein Benjamin
Schramm Vern L.
Albert Einstein College of Medicine of Yeshiva University
McKane Joseph
LandOfFree
Transition-state inhibitors for nucleoside hydrolase and transfe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transition-state inhibitors for nucleoside hydrolase and transfe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transition-state inhibitors for nucleoside hydrolase and transfe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073627